Cinchophen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C16H11NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 39Y533Z02M, chemically known as 4-quinolinecarboxylic acid, 2-phenyl- (9ci) but generally known as cinchophen, which bears US NIH Compound Identifier 8593. European Medicines Agency schedules Cinchophen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06288MIG. The term CINCHOPHEN is an International Non-Proprietary Name. World Health Organization schedules cinchophen in its Anatomical Therapeutic Chemical (ATC) Classification. CINCHOPHEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cinchophen under HS 29334910 and SITC 51575. As of Q4 2014, CINCHOPHEN remains the US FDA Preferred Term for this commodity. Cinchophen bears US NLM identifiers UMLS ID C0008793 and NCI Concept Code C87320. SMILES: OC(=O)C1C2C(NC(C1)C1CCCCC1)CCCC2.